CAMILLE SAMUELS

Camille Samuels stands as a prominent Partner at Venrock, a venerable venture capital firm renowned for its early-stage investments in transformative technology and life sciences companies. Joining Venrock in 2011, Camille has carved out a significant niche, primarily focusing on pioneering opportunities within the healthcare and biotechnology sectors. Her investment philosophy centers on identifying and nurturing companies that are poised to revolutionize patient care and scientific discovery.

As a key investor at Venrock, Camille Samuels brings a wealth of experience and a keen eye for innovation to her role. She actively seeks out early-stage ventures developing novel therapeutics, advanced diagnostics, digital health platforms, and cutting-edge medical devices. Her commitment extends beyond capital, offering strategic guidance and operational support to founders as they navigate the complex landscape of product development, regulatory approvals, and market entry.

Camille's impressive career trajectory before Venrock provided her with a robust foundation for her current endeavors. She previously held a pivotal role in business development at Genentech, a leading biotechnology corporation, where she gained invaluable insights into the intricacies of drug discovery and commercialization. Prior to Genentech, Camille honed her strategic acumen as a consultant at McKinsey & Company, advising diverse clients on critical business challenges. This unique blend of scientific understanding, strategic consulting, and business development expertise makes her an exceptionally insightful and effective investor.

Throughout her tenure at Venrock, Camille Samuels has been instrumental in backing several highly successful companies that have gone on to make significant impacts. Among her notable investments are Denali Therapeutics, a biopharmaceutical company focused on neurodegenerative diseases; Unity Biotechnology, which develops therapeutics to slow, halt, or reverse diseases of aging; and Lyra Health, a leading provider of mental health benefits. These investments underscore her ability to identify companies with strong scientific foundations and significant market potential, ultimately driving innovation that improves human health. Founders seeking strategic partners in the healthcare and biotech space often look to Camille Samuels for her deep industry knowledge and proven track record.